17 天前 - … Seventy patients were under DOACs (apixaban in 74.3%)… were under direct inhibitors
of factor Xa. Descriptive statistics (… data are available considering the new era of ACs, this …

38 天前 - … , direct oral anticoagulants (DOACs) have emerged as … apixaban therapy more
effective and safer than VKA therapy for LVT? Aim: To assess the efficacy and safety of apixaban …

43 天前 - … direct thrombin inhibitor, while rivaroxaban, apixaban, and edoxaban are Factor Xa
inhibitors. … Comparison of the efficacy and safety of new oral anticoagulants with warfarin in …

74 天前 - … reversal therapy for factor Xa (FXa) inhibitor (FXaI)–related life‐… to ask related to
any new pharmacologic agent, which in … of 92% in anti‐X activity for apixaban and rivaroxaban, …

80 天前 - … This is one of those settings in which new inhibitors of coagulation factors might
provide … (SE) and major bleeding between apixaban and warfarin in AF patients with different …

93 天前 - … and new-user design to include patients who initiated oral … -DVT (Oral Direct Factor
Xa Inhibitor Rivaroxaban in … : switch to another oral anticoagulant (eg, apixaban to edoxaban …

97 天前 - … intracranial hemorrhage and new areas of … of factor Xa inhibitor–associated bleeding
in the setting of a massive overdose. • The complex pharmacokinetic profile of apixaban in …

131 天前 - … two groups: oral direct factor Xa inhibitors (such as Rivaroxaban, Apixaban, edoxaban,
… and ATLAS 2-TIMI 51], whereas Apixaban was neither safe nor effective when used after …

147 天前 - … Chest X-ray on admission demonstrated new right lower lobe consolidation and
he commenced oral amoxicillin for presumed community-acquired pneumonia. …

150 天前 - … the medical uses of these new oral anticoagulants and their … Factor Xa inhibitors
demonstrate a dual mechanism of … Rivaroxaban and Apixaban reversibly inhibit factor Xa …